Page 8 - Presection News Today

Drs Peter Higgins and Michael Chiorean discuss risk stratification, monitoring, and treatment of Crohns disease after surgery.

An innovative study of short-course nivolumab plus ipilimumab prior to resection of MMR-deficient colon cancer has achieved unprecedented pathologic responses, with no recurrences.

The guidelines, by the American Association of Endocrine Surgeons, covers several aspects of perioperative adrenal care, including guidance on managing adrenal incidentalomas.

The incidence of leakage was three times lower when using indocyanine green fluorescence angiography. The study was published as a preprint and has not yet been peer reviewed.

For patients with squamous cell carcinoma (SCC), outcomes with chemoradiotherapy were comparable to those with esophagectomy. The study was published as a preprint and has not been peer reviewed.

Most patients with drug-resistant epilepsy should receive a referral for a surgical evaluation as soon as its clear their disease is drug resistant, new expert consensus recommendations say.

Total thyroidectomy with near-infrared autofluorescence imaging caused less short-term hypocalcemia and hypoparathyroidism, likely because there was less parathyroid gland damage, in a small, case-control study.

Adding neoadjuvant nivolumab to chemotherapy in stage IIIA/IIIB non¬–small cell lung cancer markedly improves both progression-free and overall survival over neoadjuvant chemotherapy alone.

Which is better? Concurrent neoadjuvant chemotherapy and immunotherapy or concurrent adjuvant chemotherapy with immunotherapy for non–small cell lung cancer (NSCLC)?

Call it a case of where Voltaire was correct to say, The art of medicine consists of amusing the patient while nature cures the disease.